Found 15 matching trials
Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity PHASE3 This pivotal, phase 3 study is designed to confirm the efficacy and safety ...
Show More Learn More & Join Trial
Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity PHASE3 To demonstrate statistically significant and clinically meaningful effects ...
Show More Location
Honor Health Research Institute
Learn More & Join Trial
A Trial of Setmelanotide in Acquired Hypothalamic Obesity PHASE3 The goal of this trial is to learn how well Setmelanotide works to improve ...
Show More Status
Active Not Recruiting
Location
UAN Pediatric Endocrinology
Learn More & Join Trial
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756) PHASE3 This is a sub-study of Study RM-493-040 (NCT05774756).
The goal of this su...
Show More Location
University of Alabama
Learn More & Join Trial
Setmelanotide in a Single Patient With Partial Lipodystrophy PHASE2 The objective of this single patient study is to assess the safety and effi...
Show More Location
University of Michigan
Learn More & Join Trial
Open-Label Extension Study of Setmelanotide PHASE3 This is an open-label extension study designed to evaluate the long-term sa...
Show More Location
HonorHealth Research Institute
Learn More & Join Trial
Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity PHASE3 To demonstrate statistically significant and clinically meaningful effects ...
Show More Location
Markham Stouffville Hospital
Learn More & Join Trial
Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome PHASE2 The purpose of this study was to evaluate the effects of a once daily subcu...
Show More Location
University of California Irvine
Learn More & Join Trial
Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity PHASE2 The purpose of the study was to determine the effect of setmelanotide (RM-4...
Show More Location
Synexus Clinical Research US, Inc. - Simon Williamson Clinic, PC
Learn More & Join Trial
Long Term Extension Trial of Setmelanotide PHASE2 This was a long-term extension trial to study the safety and tolerability o...
Show More Location
Synexus Clinical Research US, Inc. - Phoenix Southeast
Learn More & Join Trial